CUSIP 09062X103 · who reports it, how much, and how much it matters to them
35 of the 720 hedge fund managers we track reported shares of Biogen Inc. (Nasdaq: BIIB) on Form 13F for 30 June 2026. Between them they reported USD 471m. The largest position belongs to Citadel Advisors, at USD 90m. The manager with the most riding on it is Palo Alto Investors, where it is 4.2% of the reported book.
Compiled from SEC Form 13F filings · Hedge Fund Intelligence, PPLI.com · updated
Form 13F is filed by the manager and covers all of its accounts, so a position here belongs to the firm, not to any one fund. Not investment advice.
A list of every manager in our coverage that reported this share at the end of the quarter, taken from the filings themselves. Short positions and options are not in it.
Taken from each manager's Form 13F for 30 June 2026. A manager appears here if it reported the shares themselves; positions held only through options are left out.
The bar and the percentage show how much of the manager's reported 13F book the position makes up. Each name opens that manager's largest fund on PPLI.com, where the rest of its book is listed.
| # | Manager | Value reported | Share of its book |
|---|---|---|---|
| 1 | Citadel Advisors32 funds on PPLI.com | USD 90m | 0.0% |
| 2 | Perceptive Advisors6 funds on PPLI.com | USD 60m | 0.9% |
| 3 | Balyasny Asset Management25 funds on PPLI.com | USD 57m | 0.1% |
| 4 | Palo Alto Investors6 funds on PPLI.com | USD 30m | 4.2% |
| 5 | Adage Capital Management1 fund on PPLI.com | USD 28m | 0.0% |
| 6 | Sphera Funds Management1 fund on PPLI.com | USD 21m | 2.7% |
| 7 | Hudson Bay Capital Management8 funds on PPLI.com | USD 19m | 0.1% |
| 8 | POINT72 Asset Management17 funds on PPLI.com | USD 19m | 0.0% |
| 9 | Freestone Grove Partners1 fund on PPLI.com | USD 18m | 0.1% |
| 10 | Renaissance Technologies13 funds on PPLI.com | USD 17m | 0.0% |
| 11 | D. E. Shaw & Co.15 funds on PPLI.com | USD 16m | 0.0% |
| 12 | Cinctive Capital Management5 funds on PPLI.com | USD 16m | 0.6% |
| 13 | Farallon Capital Management56 funds on PPLI.com | USD 15m | 0.1% |
| 14 | Orbimed Advisors1 fund on PPLI.com | USD 13m | 0.2% |
| 15 | Polymer Capital Management (HK)1 fund on PPLI.com | USD 8.4m | 0.4% |
| 16 | IFM Investors Pty7 funds on PPLI.com | USD 7.8m | 0.1% |
| 17 | CIBC Asset Management69 funds on PPLI.com | USD 7.6m | 0.0% |
| 18 | Verition Fund Management3 funds on PPLI.com | USD 6.7m | 0.0% |
| 19 | Artia Global Partners1 fund on PPLI.com | USD 4m | 0.7% |
| 20 | Kinneret Advisory7 funds on PPLI.com | USD 3.9m | 0.3% |
| 21 | Marshall Wace LLP84 funds on PPLI.com | USD 2.7m | 0.0% |
| 22 | Lighthouse Investment Partners190 funds on PPLI.com | USD 1.6m | 0.0% |
| 23 | Two Sigma Investments35 funds on PPLI.com | USD 1.5m | 0.0% |
| 24 | Squarepoint Ops7 funds on PPLI.com | USD 1.5m | 0.0% |
| 25 | LMR Partners2 funds on PPLI.com | USD 1.1m | 0.0% |
| 26 | Holocene Advisors2 funds on PPLI.com | USD 1m | 0.0% |
| 27 | Trust Asset Management4 funds on PPLI.com | USD 769,000 | 0.0% |
| 28 | Exoduspoint Capital Management7 funds on PPLI.com | USD 620,000 | 0.0% |
| 29 | 9823 Capital2 funds on PPLI.com | USD 539,000 | 0.4% |
| 30 | Entrypoint Capital1 fund on PPLI.com | USD 371,000 | 0.1% |
| 31 | Fulcrum Asset Management LLP7 funds on PPLI.com | USD 335,000 | 0.0% |
| 32 | Sarissa Capital Management6 funds on PPLI.com | USD 205,000 | 0.1% |
| 33 | Bayforest Capital1 fund on PPLI.com | USD 144,000 | 0.1% |
| 34 | Walleye Capital8 funds on PPLI.com | USD 123,000 | 0.0% |
| 35 | The Quarry1 fund on PPLI.com | USD 1,512 | 0.0% |
A large manager can hold a great deal of a share and barely notice it. This table turns the question round and ranks managers by how much of their own book the position takes up.
| # | Manager | Value reported | Share of its book |
|---|---|---|---|
| 1 | Palo Alto Investors | USD 30m | 4.2% |
| 2 | Sphera Funds Management | USD 21m | 2.7% |
| 3 | Perceptive Advisors | USD 60m | 0.9% |
| 4 | Artia Global Partners | USD 4m | 0.7% |
| 5 | Cinctive Capital Management | USD 16m | 0.6% |
| 6 | Polymer Capital Management (HK) | USD 8.4m | 0.4% |
| 7 | 9823 Capital | USD 539,000 | 0.4% |
| 8 | Kinneret Advisory | USD 3.9m | 0.3% |
| 9 | Orbimed Advisors | USD 13m | 0.2% |
| 10 | Bayforest Capital | USD 144,000 | 0.1% |
Biogen Inc. trades under the symbol BIIB on the Nasdaq. Its CUSIP, the code used on Form 13F, is 09062X103.
35 of the 720 hedge fund managers PPLI.com tracks reported Biogen Inc. shares on Form 13F for 30 June 2026. The largest reported positions were held by Citadel Advisors (USD 90m), Perceptive Advisors (USD 60m), Balyasny Asset Management (USD 57m), Palo Alto Investors (USD 30m) and Adage Capital Management (USD 28m).
35 managers in our coverage reported it, and between them they run 632 funds with a file on PPLI.com. The count is of managers, because Form 13F is filed by the firm and not by each fund.
Palo Alto Investors, where the position was 4.2% of the reported 13F book at 30 June 2026.
No. Form 13F reports long positions in U.S.-listed shares and options. Short positions are not disclosed in it.
Positions are taken by PPLI.com from Form 13F filings with the U.S. Securities and Exchange Commission for the quarter shown. They are reported by each manager, cover all of its accounts and may have changed since. PPLI.com has no relationship with Biogen Inc. or with the managers listed.
Nothing here is investment, tax or legal advice, a recommendation, or an offer or solicitation to buy or sell any security. To report an error, write to the editor.
Read our Privacy Policy before submitting. Share only the information needed to describe your question; do not include medical records or account credentials.